Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 4/2010

Sonderheft 4/2010

Controversies in Breast Cancer 2010

Inhaltsverzeichnis ( 23 Artikel )

01.12.2010 | Introduction | Sonderheft 4/2010

Controversies in Breast Cancer 2010

01.12.2010 | Section introduction | Sonderheft 4/2010

Predictive and prognostic factors

01.12.2010 | Short communication | Sonderheft 4/2010

Contribution of biomarkers to personalized medicine

01.12.2010 | Short communication | Sonderheft 4/2010

Systems pathology

01.12.2010 | Section introduction | Sonderheft 4/2010

Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry

01.12.2010 | Short communication | Sonderheft 4/2010

Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics

01.12.2010 | Section introduction | Sonderheft 4/2010

The globalisation of breast cancer

01.12.2010 | Short communication | Sonderheft 4/2010

Emerging breast cancer epidemic: evidence from Africa

01.12.2010 | Short communication | Sonderheft 4/2010

Breast cancer prevention in the developing world

01.12.2010 | Short communication | Sonderheft 4/2010

The emerging breast cancer epidemic: early diagnosis and treatment

01.12.2010 | Short communication | Sonderheft 4/2010

Emerging breast cancer epidemic: impact on palliative care

01.12.2010 | Section introduction | Sonderheft 4/2010

Introduction to session on undue and disproportionate influences

01.12.2010 | Short communication | Sonderheft 4/2010

Classical peer review: an empty gun

01.12.2010 | Short communication | Sonderheft 4/2010

Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?

01.12.2010 | Section introduction | Sonderheft 4/2010

Session 6 introduction

01.12.2010 | Short communication | Sonderheft 4/2010

Designing adjuvant treatment based on biological measurements in the neoadjuvant setting

01.12.2010 | Short communication | Sonderheft 4/2010

Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations

01.12.2010 | Short communication | Sonderheft 4/2010

Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

01.12.2010 | Short communication | Sonderheft 4/2010

Angiogenesis - still a worthwhile target for breast cancer therapy?

01.12.2010 | Section introduction | Sonderheft 4/2010

Introduction: are current drug development programmes realising the full potential of new agents?

01.12.2010 | Short communication | Sonderheft 4/2010

Deciding priorities in Pharma

01.12.2010 | Short communication | Sonderheft 4/2010

Deciding priorities in a clinical studies group

01.12.2010 | Short communication | Sonderheft 4/2010

Are current development programs realising the full potential of new agents?

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise